Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Clinical trial NCT00929019 · TERMINATED
Trial details
- NCT number
- NCT00929019
- Sponsor
- Radboud University Medical Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2016-04-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.